ARCHIVES

Drug Development Effort Criticized

This article is from The Cancer Letter archive.

Vol. 01 No. 16 | April 18, 1975

Download PDF Visit The Full Archive

Related Articles

In Brief: Clinton Appoints Breast Cancer coalition’s Fran Visco to President’s Cancer Panel

May 21, 1993

House Committee Investigates Marketing Practices Of Amgen And J&J For ESAs.

April 4, 2008

Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study

June 24, 2011

Bush Appoints Seven to NCAB, Designates Runowicz as Chairman.

July 28, 2006

Amgen Cancels Rilotumumab Trials in Gastric Cancer

December 26, 2014

DCE Board Approves Recompetition Of Large Support Contracts

March 16, 1990